(19)

(11)

EP 4 540 376 A2

(12)

(88) Date of publication A3: 08.02.2024 (43) Date of publication: 23.04.2025 Bulletin 2025/17 (21) Application number: 23824718.3 (22) Date of filing: 08.06.2023

(51) International Patent Classification (IPC):  C12N 9/22(2006.01) C12N 15/85(2006.01) C07K 14/47(2006.01) C12N 7/00(2006.01) (52) Cooperative Patent Classification (CPC): C12N 9/22; C12N 15/102; C12N 15/86; C12N 2750/14143 (86) International application number: PCT/US2023/068149 (87) International publication number: WO 2023/244934 (21.12.2023 Gazette 2023/51)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA Designated Validation States: KH MA MD TN (30) Priority: 15.06.2022 US 202263352494 P (71) Applicant: Acrigen Biosciences, Inc. Kensington, CA 94708 (US)	(72) Inventors: RABUKA, David Kensington, California 94708 (US) SHARRAR, Allison Berkeley, California 94710 (US) DE TACCA, Luisa Mayumi Arake Albany, California 94706 (US) SHELLE, Michael San Francisco, California 94102 (US) (74) Representative: Glawe, Delfs, Moll  Partnerschaft mbB von Patent- und Rechtsanwälten Postfach 13 03 91 20103 Hamburg 20103 Hamburg (DE)